Ocular Hypertension: all 659 studies

Page 2 of 7. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.

• Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular HypertensionTerminatedNCT02801617Phase 3Results posted
• Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT02796560Phase 4Results posted
• The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion PressureCompletedNCT02754570Not applicableResults posted
• A Three Part Study of MGV354 in Ocular Hypertension or GlaucomaCompletedNCT02743780Phase 1/2Results posted
• A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02742649Phase 1/2Results posted
• Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®TerminatedNCT02730871Phase 4Results posted
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02674854Phase 3Results posted
• A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02636946Phase 3Results posted
• 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for GlaucomaCompletedNCT02628223Not applicableResults posted
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT02558400Phase 3Results posted
• Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02558374Phase 3Results posted
• An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertCompletedNCT02537015Phase 2Results posted
• Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both EyesCompletedNCT02512042Phase 3Results posted
• Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02507687Phase 3Results posted
• POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle GlaucomaCompletedNCT02466399Phase 2Results posted
• SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA)CompletedNCT02419508Phase 4Results posted
• Stop Retinal Ganglion Cell Dysfunction StudyTerminatedNCT02390284Phase 3Results posted
• Philadelphia Telemedicine Glaucoma Detection and Follow-Up StudyCompletedNCT02390245Not applicableResults posted
• Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle GlaucomaCompletedNCT02371746Phase 2Results posted
• Dose-Ranging Study of the Bimatoprost Ocular InsertCompletedNCT02358369Phase 2Results posted
• Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)CompletedNCT02339584Phase 3Results posted
• Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled GlaucomaCompletedNCT02338362Phase 4Results posted
• Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic SolutionCompletedNCT02325518Phase 4Results posted
• Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous PatientsCompletedNCT02278614Phase 3Results posted
• Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02250651Phase 3Results posted
• SYL040012, Treatment for Open Angle GlaucomaCompletedNCT02250612Phase 2Results posted
• Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular HypertensionCompletedNCT02247804Phase 3Results posted
• Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT02246764Phase 3Results posted
• Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular HypertensionCompletedNCT02207621Phase 3Results posted
• Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT02207491Phase 3Results posted
• Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)CompletedNCT02167035Phase 4Results posted
• An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductCompletedNCT02143843Phase 2Results posted
• 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT02140060Phase 2Results posted
• Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult VolunteersCompletedNCT02108288Phase 1Results posted
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02105285Phase 3Results posted
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02105272Phase 3Results posted
• Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT02097719Phase 4Results posted
• A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02061683Phase 4Results posted
• Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT02059278Phase 3Results posted
• Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular PressureCompletedNCT02057575Phase 2Results posted
• IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive PatientsTerminatedNCT02030886Not applicableResults posted
• A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02020512Phase 4Results posted
• Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit DoseCompletedNCT02017327Phase 4Results posted
• A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02003534Phase 4Results posted
• Efficacy of Travoprost/Timolol for Uncontrolled Intraocular PressureCompletedNCT02003391Phase 4Results posted
• A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical SettingCompletedNCT01999348Results posted
• Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension GlaucomaCompletedNCT01995136Phase 4Results posted
• Safety and Efficacy of Combigan® Ophthalmic Solution in KoreaCompletedNCT01987752Results posted
• Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01978600Phase 4Results posted
• Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in KoreaCompletedNCT01976624Results posted
• Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin AnalogueCompletedNCT01937312Phase 4Results posted
• Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®CompletedNCT01937299Phase 4Results posted
• A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or GlaucomaCompletedNCT01936389Phase 2Results posted
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01915940Phase 2Results posted
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHTCompletedNCT01895972Phase 3Results posted
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular HypertensionCompletedNCT01881126Phase 4Results posted
• A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular HypertensionCompletedNCT01863953Phase 2Results posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsCompletedNCT01853085Results posted
• A Study of LUMIGAN® RC in the Clinical SettingCompletedNCT01833741Phase 4Results posted
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT01830140Phase 3Results posted
• A Study of Bimatoprost 0.01% in the Clinical SettingCompletedNCT01814761Results posted
• A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular HypertensionTerminatedNCT01781962Results posted
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749930Phase 3Results posted
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01749904Phase 3Results posted
• An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering TreatmentsCompletedNCT01735214Results posted
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular PressureCompletedNCT01731002Phase 2Results posted
• Therapeutic Equivalence Study of Generic Brinzolamide vs AzoptCompletedNCT01722604Phase 3Results posted
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01707381Phase 2Results posted
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®CompletedNCT01664039Phase 4Results posted
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma PatientsCompletedNCT01658839Phase 1Results posted
• Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma PatientsCompletedNCT01652664Phase 3Results posted
• A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01646151Results posted
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to MonotherapyCompletedNCT01637246Results posted
• A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01632423Results posted
• A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628614Results posted
• GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to MonotherapyCompletedNCT01628601Results posted
• Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01628588Results posted
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)CompletedNCT01594970Phase 4Results posted
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01589510Results posted
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01568008Results posted
• Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) ReductionCompletedNCT01547598Phase 4Results posted
• Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)CompletedNCT01540370Results posted
• Study of AR-13324 in Patients With Elevated Intraocular PressureCompletedNCT01528787Phase 2Results posted
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionCompletedNCT01525173Phase 4Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01510145Phase 4Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01493427Phase 4Results posted
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01489670Results posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Travoprost 3-Month Safety and Efficacy StudyCompletedNCT01453855Phase 3Results posted
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01426867Phase 2Results posted
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaCompletedNCT01415401Phase 4Results posted
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01357616Phase 3Results posted
• DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01343082Phase 3Results posted
• DE-111 Against Timolol Ophthalmic Solution 0.5%CompletedNCT01342094Phase 3Results posted
• DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%CompletedNCT01342081Phase 3Results posted
• Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
• Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololCompletedNCT01336569Phase 4Results posted
• Efficacy of Changing to DUOTRAV® From Prior TherapyCompletedNCT01327599Phase 4Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01310777Phase 3Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01309204Phase 3Results posted

← Ocular Hypertension overview